U.S. Point Of Care Lipid Test Market size and share is currently valued at USD 312.04 million in 2024 and is anticipated to generate an estimated USD 553.25 Million by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 5.9% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2025 - 2034

The market’s expansion in the United States is closely tied to the healthcare system’s focus on preventive medicine and personalized care. With more than 100 million adults in the U.S. having high cholesterol, the demand for efficient lipid monitoring solutions is pressing. POC lipid tests offer a streamlined alternative to conventional laboratory testing by delivering rapid results, often within minutes, allowing healthcare providers to make immediate clinical decisions and initiate treatment interventions.

Market Growth Drivers

Several factors are propelling the growth of the U.S. POC lipid test market:

1. Rising Prevalence of Cardiovascular Diseases: Cardiovascular conditions remain the leading cause of mortality in the U.S., with a significant portion attributed to high cholesterol and other lipid abnormalities. Increasing CVD awareness has fueled the adoption of routine lipid screening at the point of care.
2. Shift Toward Preventive Healthcare: Healthcare providers and patients are increasingly emphasizing early detection and prevention. POC lipid tests facilitate this approach by providing rapid insights into patients’ cholesterol levels, enabling timely lifestyle interventions and pharmacological treatments.
3. Technological Advancements in POC Testing Devices: The development of compact, user-friendly, and highly accurate POC lipid testing devices has expanded their usability beyond hospitals and clinics to pharmacies, primary care centers, and home settings. Innovations such as smartphone-integrated devices and handheld analyzers have made lipid testing more accessible and convenient.
4. Rising Adoption of Home-Based Testing: Consumers increasingly prefer home testing options that provide privacy, convenience, and immediate results. The COVID-19 pandemic further accelerated the demand for home-based diagnostics, highlighting the importance of accessible healthcare solutions.
5. Supportive Government Initiatives and Guidelines: Various U.S. healthcare policies and recommendations, such as cholesterol management guidelines from the American Heart Association (AHA), encourage regular lipid screening, indirectly promoting the use of POC lipid tests.

Key Trends in the Market

The U.S. POC lipid test market is witnessing several notable trends shaping its growth trajectory:

1. Integration with Digital Health Platforms: Many POC devices now come with digital interfaces, enabling users to track lipid levels over time and share data with healthcare providers remotely. This integration supports telemedicine initiatives and personalized treatment plans.
2. Expansion in Pharmacy-Based Testing: Retail pharmacies are increasingly offering POC lipid testing services, providing accessible and convenient testing for a large consumer base. This trend aligns with the broader movement toward community-based healthcare.
3. Focus on Multiparameter Testing: POC devices are evolving to include multiparameter panels that assess lipid profiles along with other cardiovascular risk indicators, such as glucose or C-reactive protein (CRP). This approach supports comprehensive cardiovascular risk management.
4. Rising Demand Among Geriatric Population: The older population, which is at higher risk for lipid disorders, is increasingly adopting POC lipid tests for routine monitoring. The convenience of these tests reduces barriers to regular screening and promotes adherence to preventive care routines.
5. Partnerships and Collaborations: Leading diagnostic companies are collaborating with healthcare providers, pharmacies, and technology firms to expand the reach of POC lipid testing solutions and enhance their technological capabilities.

Research Scope

The U.S. POC lipid test market research encompasses various analytical dimensions, including market size estimation, growth forecasts, competitive landscape analysis, technological trends, and end-user adoption patterns. The market study evaluates the impact of regulatory policies, reimbursement frameworks, and public health initiatives on market growth. Additionally, research explores emerging innovations in device design, sample collection methods, and data management solutions that enhance the accuracy, efficiency, and usability of POC lipid tests.

The scope of research also includes demographic analysis, identifying key target groups such as adults at risk of cardiovascular diseases, geriatric populations, and individuals with chronic conditions like diabetes and obesity. Market opportunities are assessed across different healthcare delivery channels, including hospitals, clinics, pharmacies, and home-testing settings. Competitive benchmarking and strategic analysis of leading market players help forecast potential growth trends and investment opportunities.

Major Key Players:

• Abbott Laboratories
• Callegari Srl
• F. Hoffmann-La Roche Ltd.
• Menarini Group
• MiCoBio
• Nova Biomedical
• SD Biosensor, Inc.
• Sinocare Inc.
• VivaChek Biotech (Hangzhou) Co., Ltd.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞: https://www.polarismarketresearch.com/industry-analysis/us-point-of-care-lipid-test-market

Market Segmentation

The U.S. POC lipid test market can be segmented based on product type, sample type, end user, and application:

1. By Product Type:

• Standalone Lipid Testing Devices: Devices dedicated exclusively to lipid profile measurement.
• Multiparameter Analyzers: Devices capable of testing lipid profiles along with other health parameters such as glucose or HbA1c.

• Capillary Whole Blood: Finger-prick samples commonly used in home or clinic settings.
• Venous Blood: Used primarily in clinical and hospital environments for higher precision.

• Hospitals and Clinics: Primary sites for point of care testing due to rapid turnaround and integration with patient care.
• Pharmacies and Retail Clinics: Increasingly offering convenient lipid testing for walk-in customers.
• Home Testing: Growing segment driven by consumer preference for privacy, convenience, and remote monitoring.

• Cardiovascular Risk Assessment: Routine monitoring of lipid levels to evaluate and manage risk.
• Diabetes Management: Lipid profile assessment as part of diabetes management protocols.
• Preventive Health Screening: Early detection and lifestyle management programs aimed at reducing cardiovascular risk.

Conclusion

The U.S. point of care lipid test market is poised for substantial growth over the next decade, fueled by the rising prevalence of cardiovascular diseases, technological innovations in testing devices, and the increasing shift toward preventive and personalized healthcare. With the convergence of digital health solutions, home-testing options, and pharmacy-based services, POC lipid testing is becoming a cornerstone of modern cardiovascular care.

As healthcare providers continue to prioritize early detection and risk management, POC lipid tests will play a crucial role in enabling timely interventions, improving patient outcomes, and reducing the overall burden of cardiovascular diseases in the United States. Market players who invest in innovative, user-friendly, and connected testing solutions are well-positioned to capitalize on this expanding market and contribute to a healthier, more proactive healthcare ecosystem.

More Trending Latest Reports By Polaris Market Research:

Electric Vehicles Battery Recycling Market

Dental Consumables Market

Optical Waveguide Market

Blockchain technology Market

Dental Consumables Market

Bluetooth LE Audio Market

Europe Orthopedic Devices Market

Inulin Market

external-catheter-market